Atlas Trials

FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema

Clinical trial NCT01315990 · UNKNOWN

Trial details

NCT number
NCT01315990
Sponsor
Dr. Carl Schimanski
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Colorectal Cancer Metastatic
Start date
2011-01-01
Primary completion
2015-03-01
Enrollment
165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.